Are you Dr. Harker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 53 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3838 S 700 E
Suite 100
Salt Lake City, UT 84106Phone+1 801-269-0231Fax+1 801-269-0304
Summary
- Dr. William Harker, MD is an oncologist in Salt Lake City, Utah. He is currently licensed to practice medicine in Utah. He is affiliated with Lakeview Hospital.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1980 - 1984
Johns Hopkins UniversityResidency, Internal Medicine, 1975 - 1978
University of Utah School of MedicineClass of 1975
Certifications & Licensure
UT State Medical License 1984 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo Start of enrollment: 2006 Oct 01
- S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Start of enrollment: 2007 Jul 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Publications & Presentations
PubMed
- 109 citationsContinued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial.Gabriel N. Hortobagyi, Catherine Van Poznak, W. Graydon Harker, William J. Gradishar, Helen K. Chew
JAMA Oncology. 2017-07-01 - 140 citationsFinal 5-year results of Z-FAST trial: Adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozoleAdam Brufsky, W. Graydon Harker, J. Thaddeus Beck, Linda D. Bosserman, Charles L. Vogel
Cancer. 2012-03-01 - 19 citationsSingle agent palliative chemotherapy for end-stage Hodgkin's diseaseGraham M. Mead, W. Graydon Harker, Paula Kushlan, Saul A. Rosenberg
Cancer. 1982-09-01
